Telehorse, listed on the Warsaw Stock Exchange, has changed its name to Cannabis Poland and starts operating in the medicinal hemp industry
The first company from the medicinal hemp industry appears on the Polish stock exchange
On 13/05/2019 the company listed on Warsaw Stock Exchange changed its name to “Cannabis Poland SA”. Shareholders of the entity known so far under the name “Telehorse”, voted the resolutions on the change of activity into the hemp/cannabis industry: one of the most dynamically developing fields in many countries in the world, with the US and Canada at the forefront.
During the General Meeting, the company also voted an issue of new shares and raise capital of $800k.
Cannabis Poland plans to develop in the field of production and sale of pharmaceutical and medical products with the main focus on products containing cannabinoids produced from hemp and cannabis seeds.
The company plans to focus its activities on the production and distribution of equipment and oils for vaporizing (inhalations) of cannabinoids, as well as research on new products that meet legal requirements. It is worth noting that from November 1, 2017 in Poland it is allowed to use cannabis for medicinal purposes.
Of the several hundred substances detected in cannabis, cannabinoids such as CBD, CBC, CBG, or CBN have strong health properties. For example, cannabidiol (CBD) is most often obtained by extraction with carbon dioxide. In this way, a pure CBD is obtained, which can then be processed into an oil for oral administration or into one of the types of concentrates intended for vaporization. The vaporization of cannabinoid-rich products is considered the most effective, effective and economical method of absorption by human body. Thanks to it, cannabinoids get directly into the bloodstream in just a few seconds.
Cannabinoids are used in anti-inflammatory, analgesic, anxiolytic, antipsychotic and antispasmodic cures. They are used in Alzheimer’s disease, multiple sclerosis, leukemia, diabetes, asthma, epilepsy, spinal cord injuries, migraines, and withdrawal therapies. They help with rheumatic pains. They have antiemetic and appetite stimulating properties, which is essential for people during chemotherapy. They can also be used in the process of rehab while fighting the addiction of smoking.
The largest cannabis companies such as Canopy Growth, Aurora Cannabis and Cronos Group are listed on the stock exchanges in Canada and the USA, and their valuations respectively amount to 22 billion CAD, 11 billion CAD and 5 billion USD.
According to Prohibition Partners, the size of the cannabis medical market is estimated in 2028 in Poland at 2 billion EUR and 58 billion EUR throughout Europe.